Life Sciences Dealmaking Symposium: New Factors in the Mix: Diligence in the Time of COVID-19 | McDermott Will & Emery
To embed, copy and paste the code into your website or blog: Navigating the ever-changing global life sciences deal landscape has become more challenging in the post-pandemic world. Conducting virtual inspections and examining security and privacy risks for remote working and new operating procedures will be central to evaluating current and future collaboration partners and targets. Thinking quickly yet carefully is essential for successfully adapting to this new normal. This panel explored the critical issues that executives and investors should watch out for in a post-COVID-19 world. McDer...
Source: jdsupra.com